CompletedPhase 3NCT03128905
Trial of Colchicine Versus Prednisone for the Treatment of Acute CPPD Arthritis
Studying Familial calcium pyrophosphate deposition
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Lille Catholic University
- Principal Investigator
- Eric Houvenagel, PrLille Catholic University
- Intervention
- Colchicine opocalcium 1mg(drug)
- Enrollment
- 111 enrolled
- Eligibility
- 65 years · All sexes
- Timeline
- 2018 – 2022
Study locations (7)
- CHRU Lille, Lille, Hauts-de-France, France
- Lille Catholic Hospital, Lille, Hauts-de-France, France
- CH Valenciennes, Valenciennes, Hauts-de-France, France
- Dr Nicolas SEGAUD, Armentières, France
- Dr Rémi LEROY, Dunkirk, France
- Hôpital de Lariboisière, Paris, Île-de-France Region, France
- Hôpital Bichat, Paris, Île-de-France Region, France
Collaborators
University Hospital, Lille · Hopital Lariboisière · Bichat Hospital · Valenciennes Hospital Centre · Armentières Hospital Centre · Dunkerque Hospital Centre
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03128905 on ClinicalTrials.gov